Literature DB >> 5650138

Some effects of iproveratril (Isoptin) on the cardiovascular system.

W G Nayler, I McInnes, J B Swann, J M Price, V Carson, D Race, T E Lowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5650138

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  19 in total

1.  Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.

Authors:  D L Murdoch; G D Thomson; G G Thompson; G D Murray; M J Brodie; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Reduction of bovine pulmonary hypertension by normoxia, verapamil and hexoprenaline.

Authors:  I F McMurtry; J T Reeves; D H Will; R F Grover
Journal:  Experientia       Date:  1977-09-15

Review 3.  Calcium antagonists and their mode of action: an historical overview.

Authors:  W G Nayler; J S Dillon
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 4.  Verapamil and the myocardium.

Authors:  W G Nayler; D Krikler
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

5.  Verapamil in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D M Krikler; R A Spurrell
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

6.  Effect of verapamil in obstructive airways disease.

Authors:  T Ringqvist
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

7.  [Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].

Authors:  W Rudolph; J Kriener; W Meister
Journal:  Klin Wochenschr       Date:  1971-09-01

Review 8.  Calcium antagonists: definition and mode of action.

Authors:  W G Nayler; P Poole-Wilson
Journal:  Basic Res Cardiol       Date:  1981 Jan-Feb       Impact factor: 17.165

Review 9.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

10.  Does verapamil have a clinically significant antihypertensive effect?

Authors:  O L Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.